Symbol="ENLV"
AssetType="Common Stock"
Name="Enlivex Therapeutics Ltd"
Description="Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel."
CIK="1596812"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="37 DEREH MENACHEM BEGIN ST., 15TH FLOOR, TEL AVIV, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="45301800"
EBITDA="-25378000"
PERatio="None"
PEGRatio="None"
BookValue="2.724"
DividendPerShare="0"
DividendYield="0"
EPS="-1.43"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.22"
ReturnOnEquityTTM="-0.469"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.205"
EVToRevenue="-"
EVToEBITDA="-1.713"
Beta="0.591"
num_52WeekHigh="6.15"
num_52WeekLow="2.23"
num_50DayMovingAverage="2.728"
num_200DayMovingAverage="3.72"
SharesOutstanding="18566300"
DividendDate="2019-03-06"
ExDividendDate="None"
symbol="ENLV"
open="2.40"
high="2.48"
low="2.17"
price="2.33"
volume="72719.00"
latest_trading_day="2023-07-07"
previous_close="2.44"
change="-0.11"
change_percent="-4.5082%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="93"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="7"
Volume_recent_avg="30263"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.55"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="7"
Aroon_momentum_negative="93"
image_negative_thumbnail_id_1="92"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_negative_thumbnail_id_2="149"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0027.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="571"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_positive_thumbnail_id_1="623"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_positive_thumbnail_id_2="970"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0132.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
